Nav: Home

Science Current Events and Science News | Brightsurf | June 03, 2018


ASCO18: Trial shows how PET scans help tailor therapy for esophageal cancer
Survival results for the CALGB 80303 Trial presented at ASCO18 show that PET scan may determine which esophageal cancer patients should continue first chemotherapy and who should switch.
Is exercise associated with lower risk of death for adult survivors of childhood cancer?
Vigorous exercise is associated with reductions in the risk of death among adult survivors of childhood cancer.
ASCO: ALEX trial results show alectinib further outpacing crizotinib in ALK+ NSCLC
Updated data presented at ASCO 2018 further consolidate alectinib as the standard-of-care for first-line treatment of ALK+ non-small cell lung cancer.
ASCO18: Updated Phase 1 results of crizotinib against MET-amplified lung cancer
By lowering the bar for 'high MET amplification,' a study suggests that crizotinib may benefit more MET-amplified non-small cell lung cancer patients than previously thought.
Economic models significantly underestimate climate change risks
Policymakers are being misinformed by the results of economic models that underestimate the future risks of climate change impacts, according to a new journal paper by authors in the United States and the United Kingdom, which is published June 4, 2018.
Landmark study finds more breast cancer patients can safely forgo chemotherapy
A 21-gene test performed on tumors could enable most patients with the most common type of early breast cancer to safely forgo chemotherapy, according to a landmark study published in the New England Journal of Medicine.
A filthy first -- the 6 common types of disgust that protect us from disease revealed
Poor hygiene, animals or insects carrying disease and risky sexual behavior are among the distinct kinds of disgust that can help us to avoid disease and infection, according to new research published in a special issue of the Philosophical Transactions of the Royal Society.
Erdafitinib shows promise in urothelial cancer patients with specific mutations
In an international Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center, treatment with the oral FGFR inhibitor erdafitinib (ERDA) was well-tolerated and achieved a robust response for patients with metastatic urothelial, or urinary tract, cancers harboring mutations in the FGFR3 gene.
Study shows taking aspirin before or after coronary
New research presented at this year's Euroanaesthesia congress in Copenhagen, Denmark shows that in patients undergoing a coronary artery bypass graft (CABG) surgery, taking aspirin before and after surgery is associated with an 18 percent to 34 percent reduced mortality risk after four years.
A sense of disgust in bonobos?
Kyoto University researchers investigate the adaptive system of disgust in bonobos to further understand the origins of it in humans.
Study reveals hypnosedation as an effective alternative to general anesthesia for various surgeries
New research presented at this year's Euroanaesthesia congress in Copenhagen, Denmark shows that hypnosedation is a valuable alternative to conventional general anesthesia.
Why do some sleep-deprived people experience worse cognitive functioning than others?
The key to predicting how someone is affected by sleep loss may be found in microRNAs (miRNAs), according to a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
Forced court appearances make cops more tired, generate more citizen complaints
Results from a new study conducted by researchers at Washington State University and Central Queensland University suggest that complaints against US police officers increase when they work consecutive night shifts.

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".